Sinofn Health
Sinofn Health
The Global Paradigm Shift: The nutraceutical and pharmaceutical landscape is undergoing a massive transformation. Consumers are no longer seeking generic supplements; they are demanding clinically validated, bioavailable, and personalized nutrition solutions. As an OEM leader, SINOFN bridges the gap between raw botanical science and finished consumer products.
Technological Roadmap: Future-proofing the supply chain requires integration of AI-driven formulation and strict QC protocols. We are witnessing a shift towards "Precision Nutraceuticals," where products are customized for metabolic phenotypes—much like our work in PKU-Foods.
Industry Macro-Solution: Our manufacturing model integrates the entire value chain—from R&D at the Chinese Academy of Sciences level to BRCGS-certified warehousing. This creates an ecosystem where agility meets absolute regulatory compliance.
Dr. Tan Shengjie
Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations. Pioneering the future of clinical nutrition.
Dr. Zhang Ying
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems and molecular stabilization.
Hans van Dijk
Senior Scientist (Netherlands). EU regulatory specialist, ensuring our manufacturing exceeds global quality benchmarks.
Production Facility
Capital Investment
Proprietary Patents
Registered Trademarks
Our operations are centered in Shanghai and Tianjin, leveraging high-level logistical infrastructure to serve global markets with speed and compliance.
Yes. We operate a pilot-scale prototyping lab that allows for rapid iteration of tablets, capsules, and liquids before full-scale manufacturing, ensuring market readiness.
Absolutely. Our flexible manufacturing model allows us to tailor scopes—from niche startup formulations to massive enterprise-scale production runs.
